title: [Atypical subtrochanteric fractures after long-term bisphosphonate therapy].
abstract: There have been many reports published in recent years on atypical subtrochanteric fractures after long-term bisphosphonates therapy. In a description of a few series of cases, fractures of typical clinical course and radiological image have been documented. These fractures are estimated as very rare (2.3 per 10,000 patient-years). It is suggested that a subsequent use of steroids or proton pump inhibitors with bisphosphonates may increase the risk of fracture occurrence.
authors: Zakład Chorób Kości i Stawów, Wydział Nauk o Zdrowiu, Collegium Medicum, Uniwersytet Jagielloński, Kraków. czerwinski@kcm.pl
authors: Edward
authors: E
authors: Czerwiński
mesh_terms: D050071:Bone Density Conservation Agents / Q000009:adverse effects*; D004164:Diphosphonates / Q000009:adverse effects*; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D006620:Hip Fractures / Q000139:chemically induced*; D006801:Humans; D010024:Osteoporosis / Q000188:drug therapy*; D054328:Proton Pump Inhibitors / Q000009:adverse effects*; D012307:Risk Factors; D013256:Steroids / Q000009:adverse effects*; D013997:Time Factors
chemical_list: D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D054328:Proton Pump Inhibitors; D013256:Steroids